These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 29655578

  • 1. [Retinoblastoma metastatic to the parotid gland: A case report].
    Zrafi WS, Kanoun Belajouza S, Mestiri S, Mokni M, Bouaouina N.
    J Fr Ophtalmol; 2018 Apr; 41(4):e141-e143. PubMed ID: 29655578
    [No Abstract] [Full Text] [Related]

  • 2. A perspective on chemoreduction and focal therapy for retinoblastoma.
    Balasubramanya R, Pushker N, Bajaj MS, Ghose S, Rani A.
    Am J Ophthalmol; 2002 Oct; 134(4):633; author reply 633-4. PubMed ID: 12383837
    [No Abstract] [Full Text] [Related]

  • 3. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW.
    Int Ophthalmol Clin; 2015 Oct; 55(1):77-96. PubMed ID: 25436495
    [No Abstract] [Full Text] [Related]

  • 4. Retinoblastoma: approaching international standards for recommending chemotherapy (Commentary on Chantada et al., page 692).
    Meadows AT.
    Pediatr Blood Cancer; 2008 Mar; 50(3):521-2. PubMed ID: 18186114
    [No Abstract] [Full Text] [Related]

  • 5. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group.
    Chantada GL, Doz F, Orjuela M, Qaddoumi I, Sitorus RS, Kepak T, Furmanchuk A, Castellanos M, Sharma T, Chevez-Barrios P, Rodriguez-Galindo C, International Retinoblastoma Staging Working Group.
    Pediatr Blood Cancer; 2008 Mar; 50(3):692-4. PubMed ID: 18059037
    [Abstract] [Full Text] [Related]

  • 6. Chemoreduction in the management of retinoblastoma.
    Shields JA, Shields CL, Meadows AT.
    Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of overt extraocular retinoblastoma.
    Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E.
    Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
    [Abstract] [Full Text] [Related]

  • 8. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H, Khetan V, Halliday W, Héon E, Chan HS, Gallie BL.
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract] [Full Text] [Related]

  • 9. Treatments for Retinoblastoma Then and Now.
    Anderson HJ, Pointdujour-Lim R, Shields CL.
    JAMA Ophthalmol; 2017 Jan 12; 135(1):e164652. PubMed ID: 28030718
    [No Abstract] [Full Text] [Related]

  • 10. Current management strategies for intraocular retinoblastoma.
    Kim JW, Abramson DH, Dunkel IJ.
    Drugs; 2007 Jan 12; 67(15):2173-85. PubMed ID: 17927283
    [Abstract] [Full Text] [Related]

  • 11. Histopathologic changes in retinoblastoma after chemoreduction.
    Dithmar S, Aabert TM, Grossniklaus HE.
    Retina; 2000 Jan 12; 20(1):33-6. PubMed ID: 10696744
    [Abstract] [Full Text] [Related]

  • 12. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA, Sachdev N, Staffieri SE, McKenzie JD, Elder JE.
    J AAPOS; 2015 Feb 12; 19(1):72-4. PubMed ID: 25727592
    [Abstract] [Full Text] [Related]

  • 13. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.
    J Clin Oncol; 2003 May 15; 21(10):2019-25. PubMed ID: 12743157
    [Abstract] [Full Text] [Related]

  • 14. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT.
    Ophthalmology; 1997 Dec 15; 104(12):2101-11. PubMed ID: 9400771
    [Abstract] [Full Text] [Related]

  • 15. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
    Chantada GL, Dunkel IJ, de Dávila MT, Abramson DH.
    Br J Ophthalmol; 2004 Aug 15; 88(8):1069-73. PubMed ID: 15258027
    [Abstract] [Full Text] [Related]

  • 16. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali.
    Boubacar T, Fatou S, Fousseyni T, Mariam S, Fatoumata DT, Toumani S, Abdoul-Aziz D, Marouf KM.
    Br J Ophthalmol; 2010 Apr 15; 94(4):467-9. PubMed ID: 19822911
    [Abstract] [Full Text] [Related]

  • 17. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.
    Beck MN, Balmer A, Dessing C, Pica A, Munier F.
    J Clin Oncol; 2000 Aug 15; 18(15):2881-7. PubMed ID: 10920136
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
    Vajzovic LM, Murray TG, Aziz-Sultan MA, Schefler AC, Fernandes CE, Wolfe SC, Hess DJ, Dubovy SR.
    Arch Ophthalmol; 2010 Dec 15; 128(12):1619-23. PubMed ID: 21149791
    [No Abstract] [Full Text] [Related]

  • 19. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A.
    Klin Oczna; 2006 Dec 15; 108(1-3):55-9. PubMed ID: 16883942
    [Abstract] [Full Text] [Related]

  • 20. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, Upadhyaya A, Azad R.
    Ophthalmology; 2016 Sep 15; 123(9):1933-9. PubMed ID: 27449712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.